|
The Antibody Society was incorporated in Massachusetts on 22 February 2007, and approved by the Internal Revenue Service as a 501(c)(6) non-profit organization.
Its Articles of Organization summarize objectives of The Antibody Society as the following:
To provide an international forum for the field of recombinant antibodies, antibody engineering and related areas (“the
field”).
To facilitate the discussion and interchange of ideas regarding issues of fundamental importance for basic research, therapeutic development and clinical testing in the field.
To publish or otherwise disseminate information on issues and developments in the field.
To provide guidance, including safety guidelines for basic and applied research, as well as development and commercialization in the field.
To maintain, improve and/or integrate informatics and computational resources devoted to the field, important for its future development.
To assist the training and advancement of students, postdoctoral fellows and other new members in the field, in part through sponsorship of international scientific meetings.
|
